Addressing oral cancer treatment in COVID 19 pandemic: The Indian scenario

Authors : Ketki Kalele, Ketki Kalele, Harshal Basatwar, Harshal Basatwar

DOI : 10.18231/j.jooo.2020.011

Volume : 6

Issue : 2

Year : 2020

Page No : 41-42


Citation Data


Related Articles

Tocilizumab use during Covid-19 should alert an orthopaedic surgeon for the surgical management of arthroplasty patients: A narrative review

Gaurav Govil, Lavindra Tomar, Pawan Dhawan

Low grade appendiceal mucinous neoplasm

Sayali Shinde, Smita A Sawant

Supraclavicular Brachial Plexus Block: A Comparative Clinical Study between Bupivacaine and Levobupivacaine

Shailendra D. Chauhan, , Vyankatesh S. Joshi, Satish G. Deshpande, Deepak M. Kokane

Fecal Calprotectin as early predictor for screening and relapse in pediatric chronic diarrhea in India

Gujjarlapudi Deepika, Namburu Veeraiah, Syed Hassan Naveed, D. Nageshwar Reddy

Study of correlation between daily calorie intake (DCI) and body composition in type 2 DM patients using bioimpedance analysis as a screening tool

Sunil R Dube, Manjree Dube, Shwet Sabnis, Sayali Damle

Evaluating the efficacy of urinary trypsinogen-2 Dipstick test in diagnosing acute pancreatitis

Manoj Kumar Sethy, Manita Tamang, Dhirendra Nath Soren, Jaganath Subedhi, M Sivarama Krishna

Are we handling used metered dose inhaler canisters safely? – A call for action to address an environmental hazard

Beena Thomas, P Sukumaran, Doye George, Midhun M, Mathew Nainan

Film forming transemulgel- A novel drug delivery system

Parul Nigam, Ajay K Gupta, Akhilesh Vats

A study to compare using 0.5% of hyperbaric bupivacaine with clonidine and dexmedetomidine low dose for the lower limb surgeries in a tertiary care hospital

Ezhil Rajan, Ranjith Kumar S